Penumbra Future Growth
Future criteria checks 4/6
Penumbra is forecast to grow earnings and revenue by 44.6% and 12.4% per annum respectively. EPS is expected to grow by 44.5% per annum. Return on equity is forecast to be 12.1% in 3 years.
Key information
44.6%
Earnings growth rate
44.5%
EPS growth rate
| Medical Equipment earnings growth | 0% |
| Revenue growth rate | 12.4% |
| Future return on equity | 12.1% |
| Analyst coverage | Good |
| Last updated | 20 Nov 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 1,554 | 193 | 155 | 175 | 14 |
| 12/31/2025 | 1,363 | 147 | 178 | 159 | 17 |
| 12/31/2024 | 1,190 | 16 | 108 | 82 | 17 |
| 9/30/2024 | 1,164 | 35 | 134 | 154 | N/A |
| 6/30/2024 | 1,134 | 14 | 110 | 128 | N/A |
| 3/31/2024 | 1,096 | 93 | 104 | 122 | N/A |
| 12/31/2023 | 1,059 | 91 | 81 | 97 | N/A |
| 9/30/2023 | 995 | 41 | 46 | 62 | N/A |
| 6/30/2023 | 938 | 29 | 1 | 19 | N/A |
| 3/31/2023 | 885 | 6 | -56 | -38 | N/A |
| 12/31/2022 | 847 | -2 | -75 | -56 | N/A |
| 9/30/2022 | 830 | -31 | -90 | -66 | N/A |
| 6/30/2022 | 806 | -19 | -40 | -17 | N/A |
| 3/31/2022 | 782 | -6 | -3 | 19 | N/A |
| 12/31/2021 | 748 | 5 | -12 | 10 | N/A |
| 9/30/2021 | 710 | 34 | 0 | 17 | N/A |
| 6/30/2021 | 671 | 16 | -39 | -23 | N/A |
| 3/31/2021 | 592 | -5 | -60 | -42 | N/A |
| 12/31/2020 | 560 | -16 | -58 | -33 | N/A |
| 9/30/2020 | 539 | -10 | -55 | -26 | N/A |
| 6/30/2020 | 527 | 11 | -34 | -1 | N/A |
| 3/31/2020 | 556 | 39 | -7 | 23 | N/A |
| 12/31/2019 | 547 | 48 | 5 | 27 | N/A |
| 9/30/2019 | 523 | 45 | 32 | 29 | N/A |
| 6/30/2019 | 495 | 15 | 7 | 18 | N/A |
| 3/31/2019 | 471 | 12 | 7 | 16 | N/A |
| 12/31/2018 | 445 | 7 | 19 | 29 | N/A |
| 9/30/2018 | 420 | 9 | -12 | 20 | N/A |
| 6/30/2018 | 392 | 28 | N/A | 21 | N/A |
| 3/31/2018 | 363 | 13 | N/A | 21 | N/A |
| 12/31/2017 | 334 | 5 | N/A | 13 | N/A |
| 9/30/2017 | 311 | -7 | N/A | 3 | N/A |
| 6/30/2017 | 294 | 5 | N/A | -2 | N/A |
| 3/31/2017 | 279 | 9 | N/A | -9 | N/A |
| 12/31/2016 | 263 | 15 | N/A | -13 | N/A |
| 9/30/2016 | 245 | 18 | N/A | -11 | N/A |
| 6/30/2016 | 228 | 6 | N/A | -21 | N/A |
| 3/31/2016 | 205 | 3 | N/A | -20 | N/A |
| 12/31/2015 | 186 | 1 | N/A | -21 | N/A |
| 9/30/2015 | 167 | 0 | N/A | -18 | N/A |
| 6/30/2015 | 149 | -1 | N/A | -17 | N/A |
| 3/31/2015 | 138 | -1 | N/A | -9 | N/A |
| 12/31/2014 | 126 | -1 | N/A | -6 | N/A |
| 12/31/2013 | 89 | 1 | N/A | -3 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: PEN *'s forecast earnings growth (44.6% per year) is above the savings rate (8.1%).
Earnings vs Market: PEN *'s earnings (44.6% per year) are forecast to grow faster than the MX market (11.5% per year).
High Growth Earnings: PEN *'s earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: PEN *'s revenue (12.4% per year) is forecast to grow faster than the MX market (7.2% per year).
High Growth Revenue: PEN *'s revenue (12.4% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: PEN *'s Return on Equity is forecast to be low in 3 years time (12.1%).